Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
OLMA
|
Shane William Charles Kovacs
CH. OPERATING & FINANCIAL OFF. |
SELL
Open market or private sale
|
Direct | 16,803 Reduced 2.9% |
$157,444
$9.37 p/Share
|
Dec 10
2024 |
RELY
|
Matthew B. Oppenheimer
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 14,583 Reduced 0.33% |
$304,201
$20.86 p/Share
|
Dec 10
2024 |
NCNO
|
Insight Holdings Group, LLC |
SELL
Open market or private sale
|
Indirect | 409,148 Reduced 0.0% |
$14,802,974
$36.18 p/Share
|
Dec 10
2024 |
NCNO
|
Jeff Horing |
SELL
Open market or private sale
|
Indirect | 1,106,042 Reduced 0.0% |
$40,016,599
$36.18 p/Share
|
Dec 10
2024 |
CRCT
|
Arora Ashish
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 31,198 Reduced 0.8% |
$186,252
$5.97 p/Share
|
Dec 10
2024 |
NCNO
|
Insight Holdings Group, LLC |
SELL
Open market or private sale
|
Indirect | 473,157 Reduced 0.0% |
$17,118,820
$36.18 p/Share
|
Dec 10
2024 |
NCNO
|
Insight Holdings Group, LLC |
SELL
Open market or private sale
|
Indirect | 223,737 Reduced 0.0% |
$8,094,804
$36.18 p/Share
|
Dec 10
2024 |
ZM
|
Shane Crehan
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 1,551 Reduced 32.3% |
$131,741
$84.94 p/Share
|
Dec 10
2024 |
ZM
|
Velchamy Sankarlingam
Pres. of Engineering & Product |
SELL
Open market or private sale
|
Direct | 3,618 Reduced 3.25% |
$307,312
$84.94 p/Share
|
Dec 10
2024 |
HNST
|
Jessica Warren
Director |
SELL
Open market or private sale
|
Direct | 465,000 Reduced 28.44% |
$3,510,750
$7.55 p/Share
|
Dec 10
2024 |
APP
|
Arash Adam Foroughi
CEO & Chairperson |
SELL
Open market or private sale
|
Direct | 43,522 Reduced 1.4% |
$14,677,794
$337.25 p/Share
|
Dec 10
2024 |
APP
|
Arash Adam Foroughi
CEO & Chairperson |
SELL
Open market or private sale
|
Direct | 1,676 Reduced 0.05% |
$598,281
$356.97 p/Share
|
Dec 10
2024 |
APP
|
Arash Adam Foroughi
CEO & Chairperson |
SELL
Open market or private sale
|
Direct | 4,802 Reduced 0.15% |
$1,537,264
$320.13 p/Share
|
Dec 10
2024 |
SPFX
|
William Koppelmann
CEO |
BUY
Open market or private purchase
|
Direct | 2,500 Added 0.31% |
$4,250
$1.7 p/Share
|
Dec 10
2024 |
SNAP
|
Rebecca Morrow
CAO |
SELL
Open market or private sale
|
Direct | 32,000 Reduced 6.88% |
$397,440
$12.42 p/Share
|
Dec 10
2024 |
LDI
|
Anthony Li Hsieh
Director |
SELL
Open market or private sale
|
Indirect | 106,784 Reduced 0.0% |
$231,721
$2.17 p/Share
|
Dec 10
2024 |
LIFX
|
Russell John Burke
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,104 Reduced 1.93% |
$136,482
$43.97 p/Share
|
Dec 10
2024 |
LBRT
|
Christopher A Wright
Chairman of the Board and CEO |
SELL
Open market or private sale
|
Direct | 2,936 Reduced 0.12% |
$56,253
$19.16 p/Share
|
Dec 10
2024 |
RARE
|
Emil D Kakkis
President & CEO |
SELL
Open market or private sale
|
Indirect | 8,273 Reduced 0.0% |
$413,650
$50.0 p/Share
|
Dec 10
2024 |
SBTX
|
Richard E Lowenthal
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect | 100,000 Reduced 0.0% |
$1,317,000
$13.17 p/Share
|
Dec 10
2024 |
SBTX
|
Sarina Tanimoto
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect | 100,000 Reduced 0.0% |
$1,317,000
$13.17 p/Share
|
Dec 10
2024 |
ADGI
|
Terrance Mcguire |
SELL
Open market or private sale
|
Indirect | 175,000 Reduced 0.0% |
$103,250
$0.59 p/Share
|
Dec 10
2024 |
LSEA
|
Ming Tian |
SELL
Open market or private sale
|
Indirect | 378,260 Reduced 0.0% |
$3,877,165
$10.25 p/Share
|
Dec 10
2024 |
LSEA
|
Huaijun Chen |
SELL
Open market or private sale
|
Indirect | 534,783 Reduced 0.0% |
$5,481,525
$10.25 p/Share
|
Dec 10
2024 |
GSAT
|
L Barbee Iv Ponder
General Counsel |
SELL
Open market or private sale
|
Direct | 38,624 Reduced 1.84% |
$80,337
$2.08 p/Share
|
Dec 10
2024 |
ALEX
|
Meredith J Ching
Exec. VP, External Affairs |
SELL
Open market or private sale
|
Direct | 700 Reduced 0.47% |
$13,559
$19.37 p/Share
|
Dec 10
2024 |
BRP
|
Elizabeth Krystyn |
SELL
Open market or private sale
|
Indirect | 144,264 Reduced 0.0% |
$6,331,746
$43.89 p/Share
|
Dec 10
2024 |
FLL
|
Elaine Guidroz
SVP Secretary, General Counsel |
SELL
Open market or private sale
|
Direct | 7,948 Reduced 14.38% |
$36,083
$4.54 p/Share
|
Dec 10
2024 |
FROG
|
Frederic Simon |
SELL
Open market or private sale
|
Direct | 35,000 Reduced 0.78% |
$1,077,300
$30.78 p/Share
|
Dec 10
2024 |
VERX
|
Item Second Irr. Trust Fbo Kyle R. Westphal U/A Of Jeffrey R. Westphal Dated October 5, 2001
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 61,654 Reduced 4.58% |
$3,389,736
$54.98 p/Share
|
Dec 10
2024 |
LSEA
|
Landsea Holdings Corp |
SELL
Open market or private sale
|
Direct | 378,260 Reduced 5.81% |
$3,877,165
$10.25 p/Share
|
Dec 10
2024 |
CATY
|
Anthony M Tang
Vice Chairman |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 1.29% |
$128,800
$51.52 p/Share
|
Dec 10
2024 |
EHAB
|
Stuart M Mcguigan
Director |
BUY
Open market or private purchase
|
Direct | 15,000 Added 24.27% |
$132,150
$8.81 p/Share
|
Dec 10
2024 |
FOA
|
Lance West
Director |
SELL
Open market or private sale
|
Indirect | 23,245 Reduced 0.0% |
$513,714
$22.1 p/Share
|
Dec 10
2024 |
CULP
|
Aron R. English
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 11,794 Added 0.0% |
$59,559
$5.05 p/Share
|
Dec 10
2024 |
OPRT
|
Patrick Kirscht
Chief Credit Officer |
SELL
Open market or private sale
|
Direct | 8,403 Reduced 2.46% |
$31,931
$3.8 p/Share
|
Dec 10
2024 |
SNOW
|
Benoit Dageville
President of Products |
SELL
Open market or private sale
|
Direct | 558 Reduced 1.06% |
$99,882
$179.0 p/Share
|
Dec 10
2024 |
SNOW
|
Frank Slootman
Director |
SELL
Open market or private sale
|
Direct | 1,712 Reduced 0.82% |
$306,448
$179.0 p/Share
|
Dec 10
2024 |
SNOW
|
Christian Kleinerman
EVP, Product Management |
SELL
Open market or private sale
|
Direct | 558 Reduced 0.08% |
$99,882
$179.0 p/Share
|
Dec 10
2024 |
PASG
|
Orbimed Advisors LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 8,015 Reduced 0.0% |
$6,412
$0.8 p/Share
|
Dec 10
2024 |
QCOM
|
Alexander H Rogers
President QTL & Global Affairs |
SELL
Open market or private sale
|
Direct | 10,373 Reduced 23.71% |
$1,664,555
$160.47 p/Share
|
Dec 10
2024 |
QCOM
|
Ann C Chaplin
General Counsel&Corp Secretary |
SELL
Open market or private sale
|
Direct | 7,717 Reduced 31.03% |
$1,238,501
$160.49 p/Share
|
Dec 10
2024 |
ROAD
|
Charles E Owens
Director |
SELL
Open market or private sale
|
Indirect | 1,761 Reduced 0.0% |
$174,585
$99.14 p/Share
|
Dec 10
2024 |
PSTX
|
Mark J Gergen
President and CEO |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 4.4% |
$283,800
$9.46 p/Share
|
Dec 10
2024 |
EAST
|
Nicholas Reyland Liuzza Jr
CEO of Subsidiary |
BUY
Open market or private purchase
|
Direct | 38,165 Added 43.78% |
$31,295
$0.82 p/Share
|
Dec 10
2024 |
ATUS
|
Next Alt S.A.R.L. |
SELL
Open market or private sale
|
Direct | 805,230 Reduced 5.48% |
$19,728,135
$24.5 p/Share
|
Dec 10
2024 |
INTU
|
Laura A Fennell
EVP, People and Places |
SELL
Open market or private sale
|
Direct | 7,700 Reduced 18.5% |
$5,062,288
$657.44 p/Share
|
Dec 10
2024 |
NVTS
|
Richard J Hendrix
Director |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.0% |
$89,000
$4.45 p/Share
|
Dec 10
2024 |
NVTS
|
Gary Kent Wunderlich Jr
Director |
SELL
Open market or private sale
|
Direct | 75,000 Reduced 15.95% |
$337,500
$4.5 p/Share
|
Dec 10
2024 |
CPRX
|
Steve Miller
Chief Op. & Scientific Officer |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 6.78% |
$1,096,500
$21.93 p/Share
|
Dec 10
2024 |